FindTrial
Sign In

ABX-1431

DRUG5 trials

Sponsors

Abide Therapeutics

Conditions

Chronic Motor Tic DisorderDiabetic Peripheral NeuropathyDyspepsiaMotor Tic DisorderPainPost Herpetic NeuralgiaPost-Traumatic NeuralgiaSmall Fiber Neuropathy

Phase 1

A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
TerminatedNCT02875678
Abide TherapeuticsDyspepsia
Start: 2016-11-22End: 2017-08-07Updated: 2017-09-07
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates
CompletedNCT02929264
Abide TherapeuticsPain
Start: 2016-12-31End: 2018-03-31Updated: 2018-04-02
A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
CompletedNCT03058562
Abide TherapeuticsChronic Motor Tic Disorder, Tourette Syndrome
Start: 2017-02-01End: 2017-10-04Updated: 2017-11-06
Titration Study of ABX-1431
CompletedNCT03447756
Abide TherapeuticsDiabetic Peripheral Neuropathy, Post Herpetic Neuralgia, Post-Traumatic Neuralgia +1
Start: 2017-10-02End: 2019-05-07Updated: 2019-07-12

Phase 2

Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
CompletedNCT03625453
Abide TherapeuticsMotor Tic Disorder, Tourette Syndrome
Start: 2018-10-15End: 2020-01-20Updated: 2020-04-08